Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force…

By D.walaa badawy, L. Burke, C. Gwaltney, N. Leidy, Mona L. Martin, E. Molsen, L. Ring. Value in Health, 2011

1,009 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study (2018, background): “, International Society For Pharmacoeconomics and Outcomes Research (ISPOR) taskforce papers [4, 5], patient-reported outcome measurement information system (PROMIS) standards [27], and British Medical Journal (BMJ) guidelines for qualitative research [28]).”
Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST) (2016, neutral): “22 Median Brief-POMS (range) 14 (1-50) <.”
Electronic patient‐reported outcome systems in oncology clinical practice (2012, methodology): “The process is described in full detail by Patrick et al. 5,6 If a clinical practice is selecting an existing questionnaire for use in patient assessment, these criteria should be considered for determining whether the questionnaire was well developed for the intended use.”